Diabetic Retinopathy Preferred Practice Pattern®.

[1]  W. Benson,et al.  Late complications following cryotherapy of lattice degeneration. , 1977, American journal of ophthalmology.

[2]  T. Aaberg,et al.  Late complications of pars plana vitreous surgery. , 1978, Ophthalmology.

[3]  Curtis L. Meinert,et al.  Photocoagulation treatment of proliferative diabetic retinopathy: the second report of diabetic retinopathy study findings. , 1978, Ophthalmology.

[4]  R. Murphy,et al.  The treatment of angle neovascularization with panretinal photocoagulation. , 1979, Ophthalmology.

[5]  Four risk factors for severe visual loss in diabetic retinopathy. The third report from the Diabetic Retinopathy Study. The Diabetic Retinopathy Study Research Group. , 1979, Archives of ophthalmology.

[6]  R. Margherio,et al.  Retinopathy in juvenile-onset diabetes of short duration. , 1980, Ophthalmology.

[7]  S. Riaskoff.  Photocoagulation treatment of proliferative diabetic retinopathy. , 1981, Bulletin de la Societe belge d'ophtalmologie.

[8]  A. Schachat,et al.  Complications of vitreous surgery for diabetic retinopathy. II. Postoperative complications. , 1983, Ophthalmology.

[9]  M. Novak,et al.  Vitreous hemorrhage after vitrectomy for diabetic retinopathy. , 1984, Ophthalmology.

[10]  R. Klein,et al.  Visual impairment in diabetes. , 1984, Ophthalmology.

[11]  D L DeMets,et al.  The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. , 1984, Archives of ophthalmology.

[12]  D. DeMets,et al.  The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. , 1984, Archives of ophthalmology.

[13]  D. DeMets,et al.  Retinopathy in Young-onset Diabetic Patients , 1985, Diabetes Care.

[14]  Clinical results of pars plana vitrectomy in posterior-segment disorders. , 1985, Annals of ophthalmology.

[15]  Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Two-year results of a randomized trial. Diabetic Retinopathy Vitrectomy Study report 2. The Diabetic Retinopathy Vitrectomy Study Research Group. , 1985, Archives of ophthalmology.

[16]  R. Klein,et al.  Diabetic retinopathy as detected using ophthalmoscopy, a nonmydriatic camera and a standard fundus camera. , 1985, Ophthalmology.

[17]  Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. , 1985, Archives of ophthalmology.

[18]  R S Sobel,et al.  Fluorescein angiography complication survey. , 1986, Ophthalmology.

[19]  L. Rand,et al.  Risk of Proliferative Diabetic Retinopathy in Juvenile-Onset Type I Diabetes: A 40-yr Follow-up Study , 1986, Diabetes Care.

[20]  TECHNIQUES FOR SCATTER AND LOCAL PHOTOCOAGULATION TREATMENT OF DIABETIC RETINOPATHY: EARLY TREATMENT DIABETIC RETINOPATHY STUDY REPORT NO. 3 , 1987, International ophthalmology clinics.

[21]  INDICATIONS FOR PHOTOCOAGULATION TREATMENT OF DIABETIC RETINOPATHY: DIABETIC RETINOPATHY STUDY REPORT NO. 14 , 1987, International ophthalmology clinics.

[22]  PHOTOCOAGULATION FOR DIABETIC MACULAR EDEMA: EARLY TREATMENT DIABETIC RETINOPATHY STUDY REPORT NO. 4 , 1987, International ophthalmology clinics.

[23]  Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2. Early Treatment Diabetic Retinopathy Study Research Group. , 1987, Ophthalmology.

[24]  D L DeMets,et al.  Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. , 1988, JAMA.

[25]  J. Sunness.  The pregnant woman's eye. , 1988, Survey of ophthalmology.

[26]  H. Ahmadieh,et al.  Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Clinical application of results of a randomized trial--Diabetic Retinopathy Vitrectomy Study Report 4. The Diabetic Retinopathy Vitrectomy Study Research Group. , 1988, Ophthalmology.

[27]  Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Results of a randomized trial--Diabetic Retinopathy Vitrectomy Study Report 3. The Diabetic Retinopathy Vitrectomy Study Research Group. , 1988, Ophthalmology.

[28]  D L DeMets,et al.  The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema. , 1989, Ophthalmology.

[29]  J C Javitt,et al.  Cost effectiveness of current approaches to the control of retinopathy in type I diabetics. , 1989, Ophthalmology.

[30]  D L DeMets,et al.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. , 1989, Archives of ophthalmology.

[31]  D L DeMets,et al.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. , 1989, Archives of ophthalmology.

[32]  R. Murphy,et al.  Choroidal neovascularization after laser photocoagulation for diabetic macular edema. , 1990, Ophthalmology.

[33]  B. Klein,et al.  Effect of Pregnancy on Progression of Diabetic Retinopathy , 1990, Diabetes Care.

[34]  Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Four-year results of a randomized trial: Diabetic Retinopathy Vitrectomy Study Report 5. , 1990, Archives of ophthalmology.

[35]  UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance. , 1991, Diabetologia.

[36]  A. Kriska,et al.  The association of physical activity and diabetic complications in individuals with insulin-dependent diabetes mellitus: the Epidemiology of Diabetes Complications Study--VII. , 1991, Journal of clinical epidemiology.

[37]  Fluorescein angiographic risk factors for progression of diabetic retinopathy. ETDRS report number 13. Early Treatment Diabetic Retinopathy Study Research Group. , 1991, Ophthalmology.

[38]  Classification of diabetic retinopathy from fluorescein angiograms. ETDRS report number 11. Early Treatment Diabetic Retinopathy Study Research Group. , 1991, Ophthalmology.

[39]  Jonathan C. Javitt,et al.  Detecting and Treating Retinopathy in Patients with Tyke I Diabetes Mellitus: Savings Associated with Improved Implementation of Current Guidelines , 1991 .

[40]  Robert N. Johnson,et al.  Progressive enlargement of laser scars following grid laser photocoagulation for diffuse diabetic macular edema. , 1991, Archives of ophthalmology.

[41]  Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7. , 1991, Ophthalmology.

[42]  Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group. , 1991, Ophthalmology.

[43]  Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. , 1991, Ophthalmology.

[44]  Effects of aspirin treatment on diabetic retinopathy. ETDRS report number 8. Early Treatment Diabetic Retinopathy Study Research Group. , 1991, Ophthalmology.

[45]  Barbara E K Klein,et al.  Epidemiology of Proliferative Diabetic Retinopathy , 1992, Diabetes Care.

[46]  D. Guyer,et al.  Subretinal fibrosis after laser photocoagulation for diabetic macular edema. , 1992, American journal of ophthalmology.

[47]  W. Mieler,et al.  Submacular fibrosis after photocoagulation for diabetic macular edema. , 1992, American journal of ophthalmology.

[48]  H. Flynn,et al.  Vitrectomy in the management of diabetic eye disease. , 1992, Survey of ophthalmology.

[49]  J. A. Watters,et al.  Screening for Diabetic Retinopathy: The wide-angle retinal camera , 1993, Diabetes Care.

[50]  Risk factors for idiopathic rhegmatogenous retinal detachment. The Eye Disease Case-Control Study Group. , 1993, American journal of epidemiology.

[51]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[52]  F. Ferris,et al.  How effective are treatments for diabetic retinopathy? , 1993, JAMA.

[53]  R. Klein,et al.  The Wisconsin Epidemiologic Study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. , 1994, Archives of ophthalmology.

[54]  The Relationship of Glycemic Exposure (HbA1c) to the Risk of Development and Progression of Retinopathy in the Diabetes Control and Complications Trial , 1995, Diabetes.

[55]  E. Chew,et al.  Effects of aspirin on vitreous/preretinal hemorrhage in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report no. 20. , 1995, Archives of ophthalmology.

[56]  E. Chew,et al.  ACCOMMODATIVE AMPLITUDES IN THE EARLY TREATMENT DIABETIC RETINOPATHY STUDY: ETDRS Report Number 21 , 1995, Retina.

[57]  E. Chew,et al.  Metabolic Control and Progression of Retinopathy: The Diabetes in Early Pregnancy Study , 1995, Diabetes Care.

[58]  R. Klein.  Hyperglycemie and Microvascular and Macrovascular Disease in Diabetes , 1995, Diabetes Care.

[59]  Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group. , 1995, Ophthalmology.

[60]  The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial. , 1995, Archives of ophthalmology.

[61]  F. Ferris.  Early photocoagulation in patients with either type I or type II diabetes. , 1997, Transactions of the American Ophthalmological Society.

[62]  Jonathan Javitt,et al.  Cost-Effectiveness of Detecting and Treating Diabetic Retinopathy , 1996, Annals of Internal Medicine.

[63]  B. Hoogwerf,et al.  Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. , 1996, Archives of ophthalmology.

[64]  F. Ferris,et al.  Subretinal fibrosis in diabetic macular edema. ETDRS report 23. Early Treatment Diabetic Retinopathy Study Research Group. , 1997, Archives of ophthalmology.

[65]  N. Fineberg,et al.  Primary care physicians' practice patterns and diabetic retinopathy. Current levels of care. , 1997, Archives of family medicine.

[66]  Philip D. Harvey,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.

[67]  R. Holman,et al.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) , 1998, The Lancet.

[68]  R. Klein,et al.  Is the Risk of Diabetic Retinopathy Greater in Non-Hispanic Blacks and Mexican Americans Than in Non-Hispanic Whites With Type 2 Diabetes?: A U.S. population study , 1998, Diabetes Care.

[69]  R. Turner.  The U.K. Prospective Diabetes Study: A review , 1998, Diabetes Care.

[70]  Prevalence of diagnosed diabetes among American Indians/Alaskan Natives--United States, 1996. , 1998, MMWR. Morbidity and mortality weekly report.

[71]  Uk-Prospective-Diabetes-Study-Group.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) , 1998, The Lancet.

[72]  K. Flegal,et al.  Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994 , 1998, Diabetes Care.

[73]  F. Ferris,et al.  Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18. , 1998, Investigative ophthalmology & visual science.

[74]  Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial. , 1998, Archives of ophthalmology.

[75]  I J Constable,et al.  Non-mydriatic fundus photography: a viable alternative to fundoscopy for identification of diabetic retinopathy in an Aboriginal population in rural Western Australia? , 1998, Australian and New Zealand journal of ophthalmology.

[76]  R. Klein,et al.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. , 1998, Ophthalmology.

[77]  A. Casparie,et al.  CONTINUOUS COMPUTER SIMULATION ANALYSIS OF THE COST-EFFECTIVENESS OF SCREENING AND TREATING DIABETIC RETINOPATHY , 1999, International Journal of Technology Assessment in Health Care.

[78]  F. Ferris,et al.  Causes of severe visual loss in the early treatment diabetic retinopathy study: ETDRS report no. 24. Early Treatment Diabetic Retinopathy Study Research Group. , 1999, American journal of ophthalmology.

[79]  George A. Williams,et al.  Results after lens extraction in patients with diabetic retinopathy: early treatment diabetic retinopathy study report number 25. , 1999, Archives of ophthalmology.

[80]  W. Tamborlane,et al.  Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. , 1999, Diabetes care.

[81]  Diabetes Control.  Effect of pregnancy on microvascular complications in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. , 2000, Diabetes care.

[82]  G. Brown,et al.  The cost-effectiveness of grid laser photocoagulation for the treatment of diabetic macular edema: results of a patient-based cost-utility analysis. , 2000, Current opinion in ophthalmology.

[83]  Matthew D. Davis,et al.  Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. , 2000, The New England journal of medicine.

[84]  Michael M. Engelgau,et al.  Type 2 diabetes among North adolescents: An epidemiologic health perspective , 2000 .

[85]  T. Valle,et al.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.

[86]  P. Kaiser,et al.  Macular traction detachment and diabetic macular edema associated with posterior hyaloidal traction. , 2001, American journal of ophthalmology.

[87]  B. Munoz,et al.  Diabetes and diabetic retinopathy in a Mexican-American population: Proyecto VER. , 2001, Diabetes care.

[88]  Stephen J. Aldington,et al.  Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52) , 2001, Diabetic medicine : a journal of the British Diabetic Association.

[89]  M. Blumenkranz,et al.  The sensitivity and specificity of single-field nonmydriatic monochromatic digital fundus photography with remote image interpretation for diabetic retinopathy screening: a comparison with ophthalmoscopy and standardized mydriatic color photography. , 2002, American journal of ophthalmology.

[90]  L. Bouter,et al.  Blood pressure, lipids, and obesity are associated with retinopathy: the hoorn study. , 2002, Diabetes care.

[91]  Does direct ophthalmoscopy improve retinal screening for diabetic eye disease by retinal photography? , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[92]  Ronald Klein,et al.  Screening for diabetic retinopathy, revisited. , 2002, American journal of ophthalmology.

[93]  Michael M Engelgau,et al.  Trends in diabetes prevalence among American Indian and Alaska native children, adolescents, and young adults. , 2002, American journal of public health.

[94]  Matthew D. Davis,et al.  Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. , 2002, JAMA.

[95]  Alexander R de Leon,et al.  High-resolution stereoscopic digital fundus photography versus contact lens biomicroscopy for the detection of clinically significant macular edema. , 2002, Ophthalmology.

[96]  J. Duker,et al.  Intravitreal triamcinolone for refractory diabetic macular edema. , 2002, Ophthalmology.

[97]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .

[98]  Michael Larsen,et al.  Diabetic macular edema assessed with optical coherence tomography and stereo fundus photography. , 2002, Investigative ophthalmology & visual science.

[99]  S. Kishi,et al.  A controlled study of vitrectomy for diabetic macular edema. , 2002, American journal of ophthalmology.

[100]  F. Kaufman,et al.  Type 2 Diabetes Mellitus in Children and Youth: A New Epidemic , 2002, Journal of pediatric endocrinology & metabolism : JPEM.

[101]  R. Klein,et al.  The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes : the atherosclerosis risk in communities study. , 2002, Ophthalmology.

[102]  Stephen W. Sorensen,et al.  Lifetime risk for diabetes mellitus in the United States. , 2003, JAMA.

[103]  Ali Erginay,et al.  Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy. , 2003, American journal of ophthalmology.

[104]  Kevin Weiss,et al.  The Evidence Base for Tight Blood Pressure Control in the Management of Type 2 Diabetes Mellitus , 2003, Annals of Internal Medicine.

[105]  H. Yamashita,et al.  Early postoperative retinal thickness changes and complications after vitrectomy for diabetic macular edema. , 2003, American journal of ophthalmology.

[106]  David Maberley,et al.  Screening for diabetic retinopathy in James Bay, Ontario: a cost-effectiveness analysis. , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[107]  Gary C. Brown,et al.  CME REVIEW: A COST‐UTILITY ANALYSIS OF LASER PHOTOCOAGULATION FOR EXTRAFOVEAL CHOROIDAL NEOVASCULARIZATION , 2003, Retina.

[108]  L. Chuang,et al.  National surveillance for type 2 diabetes mellitus in Taiwanese children. , 2003, JAMA.

[109]  M. Larsen,et al.  Automated detection of diabetic retinopathy in a fundus photographic screening population. , 2003, Investigative ophthalmology & visual science.

[110]  Claude Lenfant,et al.  Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004, Circulation.

[111]  Ingrid U Scott,et al.  Single-field fundus photography for diabetic retinopathy screening: a report by the American Academy of Ophthalmology. , 2004, Ophthalmology.

[112]  M. C. Leske,et al.  The prevalence of diabetic retinopathy among adults in the United States. , 2004, Archives of ophthalmology.

[113]  D. Lackland,et al.  Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort. , 2004, Investigative ophthalmology & visual science.

[114]  R. Klein,et al.  Prevalence of diabetic retinopathy in adult Latinos: the Los Angeles Latino eye study. , 2004, Ophthalmology.

[115]  T. Jones,et al.  Increase in type 2 diabetes in children and adolescents in Western Australia , 2004, The Medical journal of Australia.

[116]  M. Lawrence,et al.  The accuracy of digital-video retinal imaging to screen for diabetic retinopathy: an analysis of two digital-video retinal imaging systems using standard stereoscopic seven-field photography and dilated clinical examination as reference standards. , 2004, Transactions of the American Ophthalmological Society.

[117]  Claude Lenfant,et al.  Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[118]  J. Silverstein,et al.  Screening for Retinopathy in the Pediatric Patient With Type 1 Diabetes Mellitus , 2005, Pediatrics.

[119]  T. Kitagawa,et al.  Annual incidence and clinical characteristics of type 2 diabetes in children as detected by urine glucose screening in the Tokyo metropolitan area. , 2005, Diabetes care.

[120]  Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481] , 2005 .

[121]  M. Colucciello.  Vision loss due to macular edema induced by rosiglitazone treatment of diabetes mellitus. , 2005, Archives of ophthalmology.

[122]  A. Keech,et al.  Fenofibrate Intervention and Event Lowering in Diabetes ( FIELD ) study : baseline characteristics and short-term effects of fenofibrate [ ISRCTN 64783481 ] The FIELD Study Investigators * , 2022 .

[123]  Philip Zeitler,et al.  The global spread of type 2 diabetes mellitus in children and adolescents. , 2005, The Journal of pediatrics.

[124]  A. Cavallerano,et al.  Nonmydriatic digital imaging alternative for annual retinal examination in persons with previously documented no or mild diabetic retinopathy. , 2005, American journal of ophthalmology.

[125]  D. Roth,et al.  INTRAVITREAL TRIAMCINOLONE ACETONIDE FOR DIABETIC MACULAR EDEMA , 2003, Retina.

[126]  Michael M. Engelgau,et al.  Prevalence of Diabetes and Impaired Fasting Glucose in Adults in the U.S. Population , 2006, Diabetes Care.

[127]  R. Ramsay,et al.  DIABETIC MACULAR EDEMA ASSOCIATED WITH GLITAZONE USE , 2006, Retina.

[128]  J. Simpson,et al.  Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial. , 2006, Ophthalmology.

[129]  A. Cavallerano,et al.  Nonmydriatic teleretinal imaging improves adherence to annual eye examinations in patients with diabetes. , 2006, Journal of rehabilitation research and development.

[130]  Ronald Klein,et al.  Noncompliance with vision care guidelines in Latinos with type 2 diabetes mellitus: the Los Angeles Latino Eye Study. , 2006, Ophthalmology.

[131]  Francesco Bandello,et al.  Optical coherence tomography versus stereoscopic fundus photography or biomicroscopy for diagnosing diabetic macular edema: a systematic review. , 2007, Investigative ophthalmology & visual science.

[132]  Lloyd Paul Aiello,et al.  Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema. , 2007, Archives of ophthalmology.

[133]  Rajiv Raman,et al.  The Sensitivity and Specificity of Nonmydriatic Digital Stereoscopic Retinal Imaging in Detecting Diabetic Retinopathy , 2007, Diabetes Care.

[134]  W. Cushman,et al.  Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. , 2007, The American journal of cardiology.

[135]  D. Goff,et al.  Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. , 2007, The American journal of cardiology.

[136]  Jeonifer M. Garren,et al.  The relationship of a diabetes telehealth eye care program to standard eye care and change in diabetes health outcomes. , 2007, Telemedicine journal and e-health : the official journal of the American Telemedicine Association.

[137]  Barbara Eden Kobrin Klein.  Overview of Epidemiologic Studies of Diabetic Retinopathy , 2007 .

[138]  T. Wong,et al.  Management of diabetic retinopathy: a systematic review. , 2007, JAMA.

[139]  Jennifer I. Lim,et al.  Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. , 2007, Ophthalmology.

[140]  George A. Williams,et al.  Laser scanning imaging for macular disease: a report by the American Academy of Ophthalmology. , 2007, Ophthalmology.

[141]  R. Avery,et al.  Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy , 2007, British Journal of Ophthalmology.

[142]  L. Aiello,et al.  Randomized trial of peribulbar triamcinolone acetonide with and without focal photocoagulation for mild diabetic macular edema: a pilot study. , 2007, Ophthalmology.

[143]  C. Lewis,et al.  A 20-Year Prospective Study of Childbearing and Incidence of Diabetes in Young Women, Controlling for Glycemia Before Conception , 2007, Diabetes.

[144]  S. Fowler,et al.  The prevalence of retinopathy in impaired glucose tolerance and recent‐onset diabetes in the Diabetes Prevention Program , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[145]  Michael E. Miller,et al.  Effects of intensive glucose lowering in type 2 diabetes. , 2008, The New England journal of medicine.

[146]  J. Shaw,et al.  Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies , 2008, The Lancet.

[147]  Rickilyn M Mancil,et al.  Outcomes of the Veterans Affairs Low Vision Intervention Trial (LOVIT). , 2008, Archives of ophthalmology.

[148]  Lloyd Paul Aiello,et al.  Comparison of time-domain OCT and fundus photographic assessments of retinal thickening in eyes with diabetic macular edema. , 2008, Investigative ophthalmology & visual science.

[149]  Lloyd Paul Aiello.  A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. , 2008, Ophthalmology.

[150]  Jennifer K. Sun,et al.  Retinal thickness on Stratus optical coherence tomography in people with diabetes and minimal or no diabetic retinopathy. , 2008, American journal of ophthalmology.

[151]  David M Nathan,et al.  Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial. , 2008, Archives of ophthalmology.

[152]  Thodoris D. Karapantsios,et al.  Standards of Medical Care in Diabetes—2008 The recommendations in this article are based on the evidence reviewed in the following publication: Standards of care for diabetes (Technical Review). Diabetes Care 17:1514–1522, 1994. Originally approved 1988. Most recent review/revision, October 2007. , 2008, Diabetes Care.

[153]  R. Klein,et al.  Clinically significant macular edema and survival in type 1 and type 2 diabetes. , 2008, American journal of ophthalmology.

[154]  G. Guyatt,et al.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations , 2008, BMJ : British Medical Journal.

[155]  Naresh Mandava,et al.  Accuracy of Primary Care Clinicians in Screening for Diabetic Retinopathy Using Single-Image Retinal Photography , 2008, The Annals of Family Medicine.

[156]  N. Bressler,et al.  Observational study of the development of diabetic macular edema following panretinal (scatter) photocoagulation given in 1 or 4 sittings. , 2009, Archives of ophthalmology.

[157]  B. Zinman,et al.  Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005). , 2009, Archives of internal medicine.

[158]  Ronald P Danis,et al.  Comparison of optical coherence tomography in diabetic macular edema, with and without reading center manual grading from a clinical trials perspective. , 2009, Investigative ophthalmology & visual science.

[159]  Judy E. Kim,et al.  Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. , 2009, Archives of ophthalmology.

[160]  S. Bressler,et al.  ASSOCIATION OF THE EXTENT OF DIABETIC MACULAR EDEMA AS ASSESSED BY OPTICAL COHERENCE TOMOGRAPHY WITH VISUAL ACUITY AND RETINAL OUTCOME VARIABLES , 2009, Retina.

[161]  T. Vignesh,et al.  Prevalence and risk factors for diabetic retinopathy: a population-based assessment from Theni District, south India , 2009, Postgraduate Medical Journal.

[162]  Ann L. Albright,et al.  Prevalence of diabetic retinopathy in the United States, 2005-2008. , 2010, JAMA.

[163]  John B Buse,et al.  Effects of combination lipid therapy in type 2 diabetes mellitus. , 2010, The New England journal of medicine.

[164]  Rodica Pop-Busui,et al.  Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial , 2010, The Lancet.

[165]  P. O S I T I O N S T A T E M E N T,et al.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[166]  Type 2 Diabetes and Persons at High Risk of Diabetes , 2010 .

[167]  Lloyd Paul Aiello,et al.  Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema , 2010, Ophthalmology.

[168]  N. Bressler,et al.  Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction. , 2010, Ophthalmology.

[169]  Elham Hatef,et al.  Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study. , 2010, Ophthalmology.

[170]  Kevin A Peterson,et al.  Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus , 2011 .

[171]  Allen C Ho,et al.  Small-gauge pars plana vitrectomy: a report by the American Academy of Ophthalmology. , 2010, Ophthalmology.

[172]  M. Kahook,et al.  In Vitro Effects of Antivascular Endothelial Growth Factors on Cultured Human Trabecular Meshwork Cells , 2010, Journal of glaucoma.

[173]  Francesco Bandello,et al.  The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. , 2011, Ophthalmology.

[174]  L. Aiello,et al.  RANDOMIZED TRIAL EVALUATING SHORT-TERM EFFECTS OF INTRAVITREAL RANIBIZUMAB OR TRIAMCINOLONE ACETONIDE ON MACULAR EDEMA AFTER FOCAL/GRID LASER FOR DIABETIC MACULAR EDEMA IN EYES ALSO RECEIVING PANRETINAL PHOTOCOAGULATION , 2011, Retina.

[175]  Lifestyle Interventions for Four Conditions: Type 2 Diabetes, Metabolic Syndrome, Breast Cancer, and Prostate Cancer , 2011 .

[176]  Jennifer K. Sun,et al.  Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. , 2011, Ophthalmology.

[177]  D. Steel,et al.  Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy. , 2011, The Cochrane database of systematic reviews.

[178]  Frank G Holz,et al.  Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema. , 2011, Ophthalmology.

[179]  Helen K. Li,et al.  Telehealth practice recommendations for diabetic retinopathy, second edition. , 2011, Telemedicine journal and e-health : the official journal of the American Telemedicine Association.

[180]  M. Ezzati,et al.  National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants , 2011, The Lancet.

[181]  N. Bressler,et al.  Retinal thickness in people with diabetes and minimal or no diabetic retinopathy: Heidelberg Spectralis optical coherence tomography. , 2012, Investigative ophthalmology & visual science.

[182]  Gary C. Brown,et al.  Anti-vascular endothelial growth factor pharmacotherapy for diabetic macular edema: a report by the American Academy of Ophthalmology. , 2012, Ophthalmology.

[183]  J. Ehrlich,et al.  Long-term effects of ranibizumab on diabetic retinopathy severity and progression. , 2012, Archives of ophthalmology.

[184]  V. Basevi.  Standards of Medical Care in Diabetes—2013 , 2012, Diabetes Care.

[185]  Z. Shan,et al.  Prevalence of Diabetic Retinopathy in Mainland China: A Meta-Analysis , 2012, PloS one.

[186]  Quan Dong Nguyen,et al.  Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. , 2012, Ophthalmology.

[187]  Ursula Schmidt-Erfurth,et al.  One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema. , 2012, Ophthalmology.

[188]  L. Aiello,et al.  Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results. , 2012, Ophthalmology.

[189]  T. Williamson,et al.  Visual and anatomical outcomes following vitrectomy for complications of diabetic retinopathy: The DRIVE UK Study , 2012, Eye.

[190]  K. Hunt,et al.  High Concentrations of AGE-LDL and Oxidized LDL in Circulating Immune Complexes Are Associated With Progression of Retinopathy in Type 1 Diabetes , 2012, Diabetes Care.

[191]  T. Peto,et al.  A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3. , 2012, Archives of ophthalmology.

[192]  G. Dorin,et al.  Subthreshold Diode Micropulse Laser Photocoagulation (SDM) as Invisible Retinal Phototherapy for Diabetic Macular Edema: A Review , 2012, Current diabetes reviews.

[193]  A. Rigby,et al.  Does severe hypoglycaemia influence microvascular complications in Type 1 diabetes? An analysis of the Diabetes Control and Complications Trial database , 2012, Diabetic medicine : a journal of the British Diabetic Association.

[194]  J. Stein,et al.  Cost-effectiveness of various interventions for newly diagnosed diabetic macular edema. , 2013, Ophthalmology.

[195]  S. Sivaprasad,et al.  Injection frequency and response to bevacizumab monotherapy for diabetic macular oedema (BOLT Report 5) , 2013, British Journal of Ophthalmology.

[196]  Q. Nguyen,et al.  Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE. , 2013, Ophthalmology.

[197]  Benjamin J. Thomas,et al.  Evolving strategies in the management of diabetic macular edema: clinical trials and current management. , 2013, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[198]  N. Bressler,et al.  Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial. , 2013, JAMA ophthalmology.

[199]  J. Manson,et al.  Prospective study of inflammatory biomarkers and risk of diabetic retinopathy in the diabetes control and complications trial. , 2013, JAMA ophthalmology.

[200]  H. Yamashita,et al.  Risk of cardiovascular diseases is increased even with mild diabetic retinopathy: the Japan Diabetes Complications Study. , 2013, Ophthalmology.

[201]  G. Quellec,et al.  Automated analysis of retinal images for detection of referable diabetic retinopathy. , 2013, JAMA ophthalmology.

[202]  P. Campochiaro,et al.  Ranibizumab for edema of the macula in diabetes study: 3-year outcomes and the need for prolonged frequent treatment. , 2013, JAMA ophthalmology.

[203]  N. Bressler,et al.  Randomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy. , 2013, JAMA ophthalmology.

[204]  A. Cavalcanti,et al.  Effect of tight blood glucose control versus conventional control in patients with type 2 diabetes mellitus: a systematic review with meta-analysis of randomized controlled trials. , 2013, Cardiovascular therapeutics.

[205]  B. Zinman,et al.  Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Advances and Contributions , 2013, Diabetes.

[206]  A. Coleman,et al.  Choosing Wisely: five ideas that physicians and patients can discuss. , 2013, Ophthalmology.

[207]  N. Bressler,et al.  Macular edema after cataract surgery in eyes without preoperative central-involved diabetic macular edema. , 2013, JAMA ophthalmology.

[208]  N. Bressler,et al.  Prevalence of and risk factors for diabetic macular edema in the United States. , 2014, JAMA ophthalmology.

[209]  V. Bezlyak,et al.  Efficacy of Anti-VEGF and Laser Photocoagulation in the Treatment of Visual Impairment due to Diabetic Macular Edema: A Systematic Review and Network Meta-Analysis , 2014, PloS one.

[210]  T. Gardner,et al.  Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment , 2014, Annals of the New York Academy of Sciences.

[211]  K. Freund,et al.  Predictors of sustained intraocular pressure elevation in eyes receiving intravitreal anti-vascular endothelial growth factor therapy. , 2014, American journal of ophthalmology.

[212]  A. Berghold,et al.  Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus. , 2014, The Cochrane database of systematic reviews.

[213]  S. Whitcup,et al.  Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. , 2014, Ophthalmology.

[214]  Jennifer K. Sun,et al.  Diabetic Retinopathy Severity and Peripheral Lesions Are Associated with Nonperfusion on Ultrawide Field Angiography. , 2015, Ophthalmology.

[215]  Jennifer K. Sun,et al.  Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial. , 2015, JAMA.

[216]  T. Olsen.  Anti-VEGF Pharmacotherapy as an Alternative to Panretinal Laser Photocoagulation for Proliferative Diabetic Retinopathy. , 2015, JAMA.

[217]  B. Hawkins,et al.  Blood pressure control for diabetic retinopathy. , 2015, The Cochrane database of systematic reviews.

[218]  Jennifer K. Sun,et al.  Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. , 2015, The New England journal of medicine.

[219]  N. S. Nair,et al.  Topical non-steroidal anti-inflammatory agents for diabetic cystoid macular oedema. , 2015, The Cochrane database of systematic reviews.

[220]  T. Wong,et al.  Interventions for Diabetic Retinopathy in Type 1 Diabetes: Systematic Review and Meta-Analysis. , 2015, American journal of ophthalmology.

[221]  Ali Erginay,et al.  CAPILLARY PLEXUS ANOMALIES IN DIABETIC RETINOPATHY ON OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY , 2015, Retina.

[222]  David J. Wilson,et al.  OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FEATURES OF DIABETIC RETINOPATHY , 2015, Retina.

[223]  P. Kaiser,et al.  Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID Studies. , 2015, Ophthalmology.

[224]  D. Maberley,et al.  ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR PROLIFERATIVE DIABETIC RETINOPATHY: A Systematic Review and Meta-Analysis , 2015, Retina.

[225]  Jennifer K. Sun,et al.  Long-term effects of therapy with ranibizumab on diabetic retinopathy severity and baseline risk factors for worsening retinopathy. , 2015, Ophthalmology.

[226]  J. Fujimoto,et al.  IMAGE ARTIFACTS IN OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY , 2015, Retina.

[227]  David Huang,et al.  Visualization of 3 Distinct Retinal Plexuses by Projection-Resolved Optical Coherence Tomography Angiography in Diabetic Retinopathy. , 2016, JAMA ophthalmology.

[228]  A. Fusco,et al.  A polymorphism of HMGA1 protects against proliferative diabetic retinopathy by impairing HMGA1-induced VEGFA expression , 2016, Scientific Reports.

[229]  R. Avery,et al.  Systemic Safety of Prolonged Monthly Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema: A Systematic Review and Meta-analysis. , 2016, JAMA ophthalmology.

[230]  Akitoshi Yoshida,et al.  Characteristics of Retinal Neovascularization in Proliferative Diabetic Retinopathy Imaged by Optical Coherence Tomography Angiography. , 2016, Investigative ophthalmology & visual science.

[231]  N. Bressler,et al.  Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial. , 2016, Ophthalmology.

[232]  Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis , 2016, The Lancet.

[233]  Carmen A. Puliafito,et al.  Quantifying Microvascular Density and Morphology in Diabetic Retinopathy Using Spectral-Domain Optical Coherence Tomography Angiography , 2016, Investigative ophthalmology & visual science.

[234]  P. Kaiser,et al.  Intravitreal Aflibercept for Diabetic Macular Edema: 148-Week Results from the VISTA and VIVID Studies. , 2016, Ophthalmology.

[235]  N. Bressler,et al.  Cost-effectiveness of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema Treatment: Analysis From the Diabetic Retinopathy Clinical Research Network Comparative Effectiveness Trial. , 2016, JAMA ophthalmology.

[236]  S. Bressler,et al.  Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab. , 2017, Ophthalmology.

[237]  P. Kaufman,et al.  Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab , 2017, JAMA ophthalmology.

[238]  Aaron Y. Lee,et al.  The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group: Report 3: Baseline Retinopathy and Clinical Features Predict Progression of Diabetic Retinopathy. , 2017, American journal of ophthalmology.

[239]  M. Wellons,et al.  Mitochondrial Haplogroups Modify the Effect of Diabetes Duration and HbA1c on Proliferative Diabetic Retinopathy Risk in Patients With Type 2 Diabetes , 2017, Investigative ophthalmology & visual science.

[240]  M. Tennant,et al.  Risk factors for progression of diabetic retinopathy in Alberta First Nations communities. , 2017, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[241]  A Lotery,et al.  Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial , 2017, The Lancet.

[242]  B. Carleton,et al.  Association of Repeated Intravitreous Bevacizumab Injections With Risk for Glaucoma Surgery , 2017, JAMA ophthalmology.

[243]  Lei Liu,et al.  Quantifying Microvascular Abnormalities With Increasing Severity of Diabetic Retinopathy Using Optical Coherence Tomography Angiography , 2017, Investigative ophthalmology & visual science.

[244]  S. Sadda,et al.  Wide-field en face swept-source optical coherence tomography angiography using extended field imaging in diabetic retinopathy , 2017, British Journal of Ophthalmology.

[245]  N. Bressler,et al.  Cost-effectiveness of Intravitreous Ranibizumab Compared With Panretinal Photocoagulation for Proliferative Diabetic Retinopathy: Secondary Analysis From a Diabetic Retinopathy Clinical Research Network Randomized Clinical Trial , 2017, JAMA ophthalmology.

[246]  B. Vanderbeek,et al.  Intravitreal Bevacizumab for the Treatment of Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy. , 2017, American journal of ophthalmology.

[247]  You-xin Chen,et al.  Antivascular endothelial growth factor agents pretreatment before vitrectomy for complicated proliferative diabetic retinopathy: a meta-analysis of randomised controlled trials , 2017, British Journal of Ophthalmology.

[248]  Jason Hsu,et al.  Quantification of Diabetic Macular Ischemia Using Optical Coherence Tomography Angiography and Its Relationship with Visual Acuity. , 2017, Ophthalmology.

[249]  T. Gardner,et al.  Diabetic retinopathy: research to clinical practice , 2017, Clinical Diabetes and Endocrinology.

[250]  Sophia Y. Wang,et al.  Incidence and Risk Factors for Developing Diabetic Retinopathy among Youths with Type 1 or Type 2 Diabetes throughout the United States. , 2017, Ophthalmology.

[251]  T. Wong,et al.  Diabetic Retinopathy in the Asia‐Pacific , 2018, Asia-Pacific journal of ophthalmology.

[252]  Osamu Sawada,et al.  Comparison between wide-angle OCT angiography and ultra-wide field fluorescein angiography for detecting non-perfusion areas and retinal neovascularization in eyes with diabetic retinopathy , 2018, Graefe's Archive for Clinical and Experimental Ophthalmology.

[253]  G. Virgili,et al.  Monotherapy laser photocoagulation for diabetic macular oedema. , 2018, The Cochrane database of systematic reviews.

[254]  Joseph L. Fontenot,et al.  Vision Rehabilitation Preferred Practice Pattern®. , 2022, Ophthalmology.

[255]  P. Mitchell,et al.  Ethnic Differences in the Prevalence and Risk Factors of Diabetic Retinopathy: The Singapore Epidemiology of Eye Diseases Study. , 2017, Ophthalmology.

[256]  Amani A. Fawzi,et al.  Importance of Considering the Middle Capillary Plexus on OCT Angiography in Diabetic Retinopathy , 2018, Investigative ophthalmology & visual science.

[257]  Jennifer K. Sun,et al.  Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema: A DRCR Network Phase 2 Randomized Clinical Trial , 2018, JAMA ophthalmology.

[258]  E. Lucenteforte,et al.  Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis. , 2018, The Cochrane database of systematic reviews.

[259]  A. Fawzi,et al.  Statistical Model of Optical Coherence Tomography Angiography Parameters That Correlate With Severity of Diabetic Retinopathy , 2018, Investigative ophthalmology & visual science.

[260]  Fen Liu,et al.  Effects of lipid-lowering agents on diabetic retinopathy: a Meta-analysis and systematic review. , 2018, International journal of ophthalmology.

[261]  Katherine E. Talcott,et al.  Loss to Follow-Up in Patients with Proliferative Diabetic Retinopathy after Panretinal Photocoagulation or Intravitreal Anti-VEGF Injections. , 2018, Ophthalmology.

[262]  D. Roth,et al.  Ranibizumab Induces Regression of Diabetic Retinopathy in Most Patients at High Risk of Progression to Proliferative Diabetic Retinopathy. , 2018, Ophthalmology. Retina.

[263]  Jennifer K. Sun,et al.  Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial , 2018, JAMA ophthalmology.

[264]  Guotong Xu,et al.  Subthreshold diode micropulse laser versus conventional laser photocoagulation monotherapy or combined with anti-VEGF therapy for diabetic macular edema: A Bayesian network meta-analysis. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[265]  C. Layton,et al.  Current Evidence for the Prevention of Endophthalmitis in Anti-VEGF Intravitreal Injections , 2018, Journal of ophthalmology.

[266]  Rishi P. Singh,et al.  Baseline Factors Affecting Changes in Diabetic Retinopathy Severity Scale Score After Intravitreal Aflibercept or Laser for Diabetic Macular Edema: Post Hoc Analyses from VISTA and VIVID. , 2018, Ophthalmology.

[267]  T. Wilt,et al.  Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians , 2018, Annals of Internal Medicine.

[268]  R. Klein,et al.  Factors Associated with Prevalent Diabetic Retinopathy in Chinese Americans: The Chinese American Eye Study. , 2017, Ophthalmology. Retina.

[269]  M. Gillies,et al.  Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema. , 2018, The Cochrane database of systematic reviews.

[270]  Dengwang Li,et al.  Evaluation of Automatically Quantified Foveal Avascular Zone Metrics for Diagnosis of Diabetic Retinopathy Using Optical Coherence Tomography Angiography , 2018, Investigative ophthalmology & visual science.

[271]  P. Hsiao,et al.  Association Between Metabolic Syndrome and Microvascular and Macrovascular Disease in Type 2 Diabetic Mellitus , 2017, The American journal of the medical sciences.

[272]  Fitriani Fitriani,et al.  THE PREVALENCE OF DIABETIC RETINOPATHY , 2018 .

[273]  B. Bruce,et al.  Randomized Trial of Treat and Extend Ranibizumab With and Without Navigated Laser Versus Monthly Dosing for Diabetic Macular Edema: TREX-DME 2-Year Outcomes. , 2019, American journal of ophthalmology.

[274]  Stela Vujosevic,et al.  EARLY MICROVASCULAR AND NEURAL CHANGES IN PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES MELLITUS WITHOUT CLINICAL SIGNS OF DIABETIC RETINOPATHY , 2017, Retina.

[275]  Mitochondrial haplogroups are not associated with diabetic retinopathy in a large Australian and British Caucasian sample , 2019, Scientific Reports.

[276]  K. Schaal,et al.  VASCULAR ABNORMALITIES IN DIABETIC RETINOPATHY ASSESSED WITH SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY WIDEFIELD IMAGING , 2017, Retina.

[277]  Jennifer K. Sun,et al.  Rationale and Application of the Protocol S Anti-Vascular Endothelial Growth Factor Algorithm for Proliferative Diabetic Retinopathy. , 2019, Ophthalmology.

[278]  P. Rosenfeld,et al.  Longitudinal Wide-Field Swept-Source OCT Angiography of Neovascularization in Proliferative Diabetic Retinopathy after Panretinal Photocoagulation. , 2019, Ophthalmology. Retina.

[279]  Jennifer K. Sun,et al.  Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial. , 2019, JAMA.

[280]  S. Garg,et al.  Association of Statin Therapy With Prevention of Vision-Threatening Diabetic Retinopathy , 2019, JAMA ophthalmology.

[281]  C. Regillo,et al.  Outcomes of Eyes Lost to Follow-up with Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation versus Intravitreal Anti-Vascular Endothelial Growth Factor. , 2019, Ophthalmology.

[282]  Grading Diabetic Retinopathy from Stereoscopic Color Fundus Photographs - An Extension of the Modified Airlie House Classification: ETDRS Report Number 10. , 2020, Ophthalmology.